Dr Andy Blackwell speaks to pharmaphorum about ieso’s latest study conducted with support from Roche Diabetes Ltd
ieso’s Group Chief Science and Strategy Officer, Dr Andy Blackwell recently featured in pharmaphorum's article “Beyond the pill in an outcome-based world”.
It examines how pharmaceutical-led patient support programmes can be supplemented and supported by additional healthcare interventions, particularly mental health support. Andy explained to her how our recent study, conducted with support from Roche Diabetes Care Limited, found that tailored, online cognitive behavioural therapy (CBT) can not only improve mental health outcomes for diabetes patients, but can also boost quality of life, reduce diabetes distress, and, crucially, improve self-management of their condition.
Read the full article here. If you’d like to read more about our further scientific research, click here.
About pharmaphorum:
pharmaphorum combines industry-leading publications, strategic consulting and a content-driven stakeholder engagement agency. pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.
